ARC
MDCO

Absolute Return Capital’s Medicines Co MDCO Stock Holding History

Absolute Return Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,417
Closed -$157K – 1062
2014
Q2 		$157K Buy
+5,417
New +$145K ﹤0.01% 1058

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Absolute Return Capital's MDCO Position: Q3 2014 in Review

Absolute Return Capital sold out of Medicines Co (MDCO) in Q3 2014, closing a stake of 5,417 shares — an estimated $157K sold.

Absolute Return Capital first reported a position in MDCO in Q2 2014 and held it in 1 quarter. The position peaked at $157K in Q2 2014. 152 funds tracked by Wall St. Rank hold MDCO as of Q3 2014.

  • Absolute Return Capital reported no remaining Medicines Co position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 5,417 Medicines Co shares in Q3 2014, an estimated $157K.
  • Absolute Return Capital first reported a position in Medicines Co in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's Medicines Co position peaked at $157K in Q2 2014.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.